Selective Serotonin Reuptake Inhibitors: all 1,366 studies that test it
Page 9 of 14. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With SchizophreniaCompletedNCT02137993Phase 4
- Antipsychotic to Treat Psychosis SyndromeStatus unknownNCT02137616Not applicable
- A Clinical Trial to Investigate the Pharmacokinetics and the Effect on ECG of Escitalopram in Elderly VolunteersCompletedNCT02122939Phase 1
- A Randomised Trial of Sertraline, Cognitive Behaviour Therapy & Combined Therapy for Postnatal DepressionCompletedNCT02122393Phase 3
- Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With DeliriumWithdrawnNCT02118688Phase 4
- Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Citalopram on MotivationCompletedNCT02113943Phase 2
- Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or PlaceboCompletedNCT02097147Phase 1
- Mechanism of tDCS-induced Learning Enhancement - the Role of SerotoninCompletedNCT02092974Phase 1
- Trazodone Once a Day in Major Depression DisorderCompletedNCT02086929Phase 3
- Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male SubjectsCompletedNCT02072278Phase 1
- "Evaluation by Transcranial Magnetic Stimulation of the Benefit of Fluoxetine on Motor Recovery After Stroke"TerminatedNCT02063425Not applicable
- Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction StudyCompletedNCT02051387Phase 1
- The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar DepressivesWithdrawnNCT02028026Phase 4
- Objective Diagnostic Markers and Personalized Intervention in MDD PatientsStatus unknownNCT02023567Not applicable
- Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD PatientsCompletedNCT02022709Phase 4
- Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With FluvoxamineCompletedNCT02016261Phase 4
- Neuroimaging Predictors of Antidepressant Treatment OutcomeWithdrawnNCT02000726Phase 2
- Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive DisorderStatus unknownNCT01997580Phase 4
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fed ConditionCompletedNCT01996475Phase 1
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fasting ConditionCompletedNCT01996462Phase 1
- Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects (RECITAL).CompletedNCT01978782Phase 1
- Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic EpisodeCompletedNCT01977300Phase 3
- A Study of the Effect of Multiple Doses of Itraconazole and Fluoxetine on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy SubjectsCompletedNCT01967979Phase 1
- RCT of a Neuroplasticity Agent and CI Therapy for Severe Arm Paresis After StrokeWithdrawnNCT01963832Phase 2
- Antidepressants, Emotions and PersonalityCompletedNCT01946607Not applicable
- The Efficacy of Citalopram Treatment in Acute StrokeCompletedNCT01937182Phase 2
- Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and DapoxetineStatus unknownNCT01928563Phase 1
- Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome PatientsWithdrawnNCT01916200Phase 4
- MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation TrialCompletedNCT01910259Phase 2
- Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male VolunteersCompletedNCT01908296Phase 1
- Negative Valence Brain Targets and Predictors of Anxiety and Depression TreatmentCompletedNCT01903447Phase 4
- Comparative Efficacy and Acceptability of Antimanic Drugs in Acute ManiaStatus unknownNCT01893229Phase 4
- Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic DrugsCompletedNCT01871701Phase 1
- Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar DisorderCompletedNCT01864551Phase 4
- Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?TerminatedNCT01856127Phase 4
- Interaction Between Paroxetine and TelaprevirTerminatedNCT01841502Phase 2
- Escitalopram for the Treatment of Depression in Alzheimer's DiseaseCompletedNCT01841125Phase 4
- Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia PatientsStatus unknownNCT01832285Not applicable
- Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major DepressionCompletedNCT01824433Phase 4
- An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety SymptomsCompletedNCT01814098Phase 4
- A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe DepressionCompletedNCT01814085Phase 4
- Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical ImplicationsStatus unknownNCT01796132Phase 4
- Serotonergic Modulation of Motor Function in Subacute and Chronic SCIStatus unknownNCT01788969Phase 1
- Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDASWithdrawnNCT01769027Phase 2
- Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI)Status unknownNCT01753882Phase 1
- Enhanced Motor Recovery Using Serotonergic Agents in StrokeCompletedNCT01751854Phase 1
- Late-life Depression and Cerebral PerfusionWithdrawnNCT01751828Not applicable
- Bioequivalence Study of Escitalopram Tablets 10 mgCompletedNCT01745601Phase 1
- Fluoxetine for Motor Recovery After Acute Intracerebral HemorrhageTerminatedNCT01737541Phase 3
- Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With CancerCompletedNCT01725048Early Phase 1
- Vilazodone for the Treatment of Posttraumatic Stress DisorderCompletedNCT01715519Phase 4
- Study of Vilazodone to Treat Social Anxiety DisorderStatus unknownNCT01712321Not applicable
- Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 GenotypesCompletedNCT01704638Phase 1
- Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.CompletedNCT01700270Phase 1
- Role of Inflammation Factors and Insulin Resistance in Major Depressive DisorderStatus unknownNCT01699490Phase 4
- Pharmacokinetic Properties of Lu AA21004 (Vortioxetine) in Healthy Young Chinese Men and WomenCompletedNCT01676571Phase 1
- Fluoxetine for Motor, Aphasia, and Neglect Recovery After Ischemic StrokeWithdrawnNCT01674868Not applicable
- Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)CompletedNCT01672255Early Phase 1
- Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective DizzinessCompletedNCT01669304Phase 1
- Citalopram for Sx/Util in Acute Coronary Syndrome PatientsWithdrawnNCT01667744Phase 1/2
- A Study of the Effect of Fluvoxamine on the Pharmacokinetics of RO4917523 in Healthy VolunteersCompletedNCT01665404Phase 1
- Serotonergic System and Violent Video GamesCompletedNCT01644071Not applicable
- A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of EscitalopramCompletedNCT01638689Phase 1
- Sequence Towards Remission in DepressionStatus unknownNCT01628783Phase 4
- Fluoxetine Prevention TrialWithdrawnNCT01615055Early Phase 1
- Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to MonotherapyCompletedNCT01609153Phase 4
- A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five AntipsychoticsCompletedNCT01607762Phase 1
- Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in ControlsCompletedNCT01607125Phase 1
- Modafinil - Escitalopram Study for Cocaine DependenceCompletedNCT01601730Phase 1
- Lexapro®'s Efficacy After Dose Escalation in Remission StudyCompletedNCT01594866Phase 4
- The Effects of Escitalopram on CytokinesStatus unknownNCT01587326Not applicable
- Citalopram vs Clomipramine vs Placebo in Recurrent DepressionCompletedNCT01575158Not applicable
- Safety and Efficacy of Vilazodone in Major Depressive DisorderCompletedNCT01573598Phase 4
- The Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With PsychotherapyCompletedNCT01569685Phase 4
- Escitalopram Treatment In Acute StrokeWithdrawnNCT01561092Phase 4
- Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic DisorderCompletedNCT01551225Phase 4
- Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive DisorderCompletedNCT01541475Phase 4
- Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, FluvoxamineCompletedNCT01540500Phase 1
- Early Recognition and Optimal Treatment of Delirium in Patients With Advanced CancerCompletedNCT01539733Not applicable
- Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord InjuryCompletedNCT01538693Not applicable
- Escitalopram in the Treatment of Postpartum DepressionCompletedNCT01527474Not applicable
- A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of DepressionCompletedNCT01524497Phase 2/3
- Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) ExacerbationsWithdrawnNCT01522092Phase 3
- Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed ConditionCompletedNCT01503450Phase 1
- Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting ConditionCompletedNCT01503437Phase 1
- Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed StudyCompletedNCT01503424Phase 1
- Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01503398Phase 1
- Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy EvaluationCompletedNCT01485692Not applicable
- Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)Status unknownNCT01483053Phase 4
- Cognitive Correlates of Antidepressant Treatment Response in EldersCompletedNCT01477268Phase 4
- Multimodal Assessment of Neurobiological Markers for Psychiatric DisordersCompletedNCT01477203Phase 4
- A Double-blind Placebo Controlled Trial of Sentra PM, a Medical FoodCompletedNCT01468038Phase 3
- Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early ImprovementCompletedNCT01458626Phase 4
- Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive DisorderCompletedNCT01454635Not applicable
- Bergen Psychosis Project 2 - The Best Intro StudyCompletedNCT01446328Phase 4
- Trial of PED-1 in Male Patients With Premature EjaculationCompletedNCT01439984Phase 3
- Analgesic Effect of Escitalopram in Total Knee Arthroplasty (TKA)CompletedNCT01430520Phase 4
- Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044CompletedNCT01419470Phase 1/2
- A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy VolunteersCompletedNCT01418274Phase 1
- Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk PrediabeticsCompletedNCT01411930Phase 4